AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $552,970 | -21.0% | 7,912 | -18.8% | 0.01% | -20.0% |
| Q2 2023 | $699,916 | +16.9% | 9,740 | +0.4% | 0.02% | +7.1% |
| Q1 2023 | $598,604 | -4.0% | 9,705 | +20.1% | 0.01% | -22.2% |
| Q4 2022 | $623,519 | +47.1% | 8,084 | -15.0% | 0.02% | +12.5% |
| Q3 2022 | $424,000 | +16.8% | 9,511 | +0.3% | 0.02% | 0.0% |
| Q2 2022 | $363,000 | -7.6% | 9,480 | -0.1% | 0.02% | +6.7% |
| Q1 2022 | $393,000 | +4.8% | 9,487 | -5.3% | 0.02% | +15.4% |
| Q4 2021 | $375,000 | +14.0% | 10,017 | -1.2% | 0.01% | 0.0% |
| Q3 2021 | $329,000 | -28.9% | 10,137 | +47.7% | 0.01% | -31.6% |
| Q2 2021 | $463,000 | +33.0% | 6,864 | +11.8% | 0.02% | +18.8% |
| Q1 2021 | $348,000 | -26.7% | 6,141 | -6.6% | 0.02% | -36.0% |
| Q4 2020 | $475,000 | +64.4% | 6,577 | +62.3% | 0.02% | +25.0% |
| Q3 2020 | $289,000 | +7125.0% | 4,053 | +2602.0% | 0.02% | – |
| Q2 2019 | $4,000 | – | 150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,123,929 | $42,462,000 | 36.04% |
| MORGAN JESS S & CO INC | 114,525 | $4,327,000 | 2.66% |
| Fairmount Funds Management LLC | 187,598 | $7,087,000 | 2.34% |
| WMS Partners, LLC | 242,500 | $9,162,000 | 1.95% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 610,064 | $23,048,000 | 1.41% |
| MANGROVE PARTNERS IM, LLC | 400,000 | $15,112,000 | 0.90% |
| RTW INVESTMENTS, LP | 1,618,819 | $61,159,000 | 0.89% |
| MPM BioImpact LLC | 103,405 | $3,907,000 | 0.71% |
| Avidity Partners Management LP | 775,000 | $29,280,000 | 0.62% |
| FIRST MIDWEST BANK TRUST DIVISION | 115,028 | $4,346,000 | 0.56% |